CDC reporting unit 271
Fertility Centers of Orange County
17875 Von Karman Ave, Suite 480, Irvine, CA 92614 · address reported for 2022.
Own-egg outcomes
Live-birth deliveries per intended retrieval, all diagnoses, for retrievals started in 2021 and linked transfers within 12 months. Age is at retrieval start. Native fractions and protected/missing states are preserved.
| Patient age | Published outcome | Matching intended retrievals |
|---|---|---|
| <35 | 49.3% | 71 |
| 35-37 | 38.6% | 88 |
| 38-40 | 25.0% | 132 |
| >40 | 6.8% | 73 |
Read these results
<35: About 49 in 100 retrieval attempts led to a live-birth delivery.
35-37: About 39 in 100 retrieval attempts led to a live-birth delivery.
38-40: About 25 in 100 retrieval attempts led to a live-birth delivery.
>40: About 7 in 100 retrieval attempts led to a live-birth delivery.
Treatment choices to discuss
<35 · Genetic testing was more common.
95.4% · National: 53.6%
Which test would you recommend for me, is it optional, and what does it cost?
Understanding embryo testing
Ask which test is proposed, why, and what it changes for you.
PGT includes tests for different purposes. PGT-A screens chromosome number; PGT-M tests for a particular inherited condition; PGT-SR addresses structural chromosome rearrangements.
What the data show
CDC reports PGT use broadly. These figures do not identify the test, establish a requirement, or show that testing caused better results.
ASRM has not established a benefit from routine PGT-A screening for every IVF patient. A higher success rate after transfer does not by itself establish a benefit per retrieval.
Ask the clinic
- Which test would you recommend for me?
- Is it optional, and what are the alternatives?
- What happens if no embryo is recommended for transfer?
- Are biopsy and laboratory testing separate charges?
Source: ASRM PGT-A opinion.
35-37 · Genetic testing was more common.
95.7% · National: 63.8%
Which test would you recommend for me, is it optional, and what does it cost?
Understanding embryo testing
Ask which test is proposed, why, and what it changes for you.
PGT includes tests for different purposes. PGT-A screens chromosome number; PGT-M tests for a particular inherited condition; PGT-SR addresses structural chromosome rearrangements.
What the data show
CDC reports PGT use broadly. These figures do not identify the test, establish a requirement, or show that testing caused better results.
ASRM has not established a benefit from routine PGT-A screening for every IVF patient. A higher success rate after transfer does not by itself establish a benefit per retrieval.
Ask the clinic
- Which test would you recommend for me?
- Is it optional, and what are the alternatives?
- What happens if no embryo is recommended for transfer?
- Are biopsy and laboratory testing separate charges?
Source: ASRM PGT-A opinion.
38-40 · Genetic testing was more common.
94.7% · National: 65.6%
Which test would you recommend for me, is it optional, and what does it cost?
Understanding embryo testing
Ask which test is proposed, why, and what it changes for you.
PGT includes tests for different purposes. PGT-A screens chromosome number; PGT-M tests for a particular inherited condition; PGT-SR addresses structural chromosome rearrangements.
What the data show
CDC reports PGT use broadly. These figures do not identify the test, establish a requirement, or show that testing caused better results.
ASRM has not established a benefit from routine PGT-A screening for every IVF patient. A higher success rate after transfer does not by itself establish a benefit per retrieval.
Ask the clinic
- Which test would you recommend for me?
- Is it optional, and what are the alternatives?
- What happens if no embryo is recommended for transfer?
- Are biopsy and laboratory testing separate charges?
Source: ASRM PGT-A opinion.
>40 · Genetic testing was more common.
85.7% · National: 52.9%
Which test would you recommend for me, is it optional, and what does it cost?
Understanding embryo testing
Ask which test is proposed, why, and what it changes for you.
PGT includes tests for different purposes. PGT-A screens chromosome number; PGT-M tests for a particular inherited condition; PGT-SR addresses structural chromosome rearrangements.
What the data show
CDC reports PGT use broadly. These figures do not identify the test, establish a requirement, or show that testing caused better results.
ASRM has not established a benefit from routine PGT-A screening for every IVF patient. A higher success rate after transfer does not by itself establish a benefit per retrieval.
Ask the clinic
- Which test would you recommend for me?
- Is it optional, and what are the alternatives?
- What happens if no embryo is recommended for transfer?
- Are biopsy and laboratory testing separate charges?
Source: ASRM PGT-A opinion.
2022 transfers, all diagnoses and egg sources. Matching transfer counts are not published here. Reported use does not establish current policy or explain outcomes.
Costs
Example range
$14,000–$18,000+per cycle
IVF
- Medication
- Extra, price not listed
- Embryo transfer
- $3,000–$4,000 separate
- Genetic testing
- From $3,000 extra
- Base-cycle inclusions
- Ask clinic
Additional fees may apply. Confirm current fees and eligibility.
Get a full quote
Ask for a written, itemized quote covering:
- Tests, monitoring and medication
- Retrieval and anesthesia
- Fertilization, ICSI and genetic testing
- Freezing, storage and transfers
Confirm cancellation fees, refund terms and who bills each item.
Check IVF and medication coverage, exclusions, prior authorization and benefit limits with your insurer. Accepting your insurance does not guarantee IVF coverage.
Source
Research: 2026-10-13. Prices not independently verified here.
Adapted from IVFcost.co · CC BY 4.0.
Donor treatment outcomes
Live-birth deliveries per transfer in 2022, all recipient ages and all diagnoses. Donated embryos remain a separate population.
| Published transfer pathway | Published outcome | Matching transfers |
|---|---|---|
| Fresh Embryos Fresh Eggs | No matching cycles | 0 |
| Fresh Embryos Frozen Eggs | No matching cycles | 0 |
| Frozen Embryos | 9 / 12 | 12 |
| Donated Embryos | No matching cycles | 0 |
Combined donor-egg pathways: 9 / 12. Matching transfers: 12. This site weights the three donor-egg pathways by their matching transfer counts; a ~ marker identifies approximation from rounded published rates. Missing or protected active inputs prevent a combined rate.
Reported activity
Annual ART cycles are attempts, not unique patients. Unlinked and unavailable years remain gaps.
| Report year | Annual cycles |
|---|---|
| 2013 | Not linked to this reporting unit |
| 2014 | Not linked to this reporting unit |
| 2015 | Not linked to this reporting unit |
| 2016 | Not linked to this reporting unit |
| 2017 | Not linked to this reporting unit |
| 2018 | Not reported |
| 2019 | Not reported |
| 2020 | Not reported |
| 2021 | 693 |
| 2022 | 668 |
Reported services
| Service | CDC value |
|---|---|
| Donor egg services | Yes |
| Donated embryo services | No |
| Embryo cryopreservation services | Yes |
| Egg cryopreservation services | Yes |
| Gestational carrier services | Yes |
History and coverage, 2013–2022
Ten report years are checked individually. A missing or uncertain identity link stays a gap; it is not a zero or evidence of closure. A shared CDC reporting ID does not mean the same doctors or offices were included in every year. Calendar-year fresh-cycle measures and cumulative retrieval cohorts are different populations.
| Report year | Coverage | Native reporting name | Explanation |
|---|---|---|---|
| 2013 | not linked | No confirmed match | No unique source-name match; this is not evidence that the clinic did not operate. |
| 2014 | not linked | No confirmed match | No unique source-name match; this is not evidence that the clinic did not operate. |
| 2015 | not linked | No confirmed match | No unique source-name match; this is not evidence that the clinic did not operate. |
| 2016 | not linked | No confirmed match | No unique source-name match; this is not evidence that the clinic did not operate. |
| 2017 | not linked | No confirmed match | No unique source-name match; this is not evidence that the clinic did not operate. |
| 2018 | nonreporting | FERTILITY CENTERS OF ORANGE COUNTY | Linked using the original CDC records. The doctors and offices included in the report may have changed between years. |
| 2019 | not linked | No confirmed match | No source data under this reporting ID; no predecessor substituted. |
| 2020 | not linked | No confirmed match | No source data under this reporting ID; no predecessor substituted. |
| 2021 | reported | Fertility Centers of Orange County | Same published CDC reporting ID; year-specific metadata retained. |
| 2022 | reported | Fertility Centers of Orange County | Published 2022 reporting unit; source status: Open |
2021 · native reported outcomes
Fertility Centers of Orange County · all diagnoses. Numeric outcome values are native percentages; fractions and protected strings remain as published.
| Age or pathway | Native population | Published value | Value state |
|---|---|---|---|
| <35 | Own eggs · intended retrievals started in 2020; linked transfers within 12 months | 0.0 | no cycles |
| 35-37 | Own eggs · intended retrievals started in 2020; linked transfers within 12 months | 0.0 | no cycles |
| 38-40 | Own eggs · intended retrievals started in 2020; linked transfers within 12 months | 0.0 | no cycles |
| >40 | Own eggs · intended retrievals started in 2020; linked transfers within 12 months | 0.0 | no cycles |
| Fresh Embryos Frozen Eggs | Donor / donated-embryo transfers in 2021 | 0.0 | no cycles |
| Frozen Embryos | Donor / donated-embryo transfers in 2021 | "*/10" | suppressed |
| Donated Embryos | Donor / donated-embryo transfers in 2021 | 0.0 | no cycles |
| Fresh Embryos Fresh Eggs | Donor / donated-embryo transfers in 2021 | 0.0 | no cycles |
Current native observations (JSON) · 2013–2022 history and coverage (JSON) · Citation
Original sources and context
Every outcome above uses its original CDC population. Select an underlined figure in the interactive explorer for its native definition, footnote and source. The explorer also includes reviewed history, patient mix, national references and clinic-figure exports.